FILING ANALYSIS · THURSDAY, NOVEMBER 12
Kodiak Sciences Inc. KOD — 8-K: Results of Operations and Financial Condition
negative
Kodiak Sciences raised $69 million through an at-the-market equity offering, which will lead to dilution, and reported a net loss of $66.2 million for the third quarter of 2026, with R&D expenses increasing to $58.3 million.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →